Clinical Trials Browser

NCT04266093 2026-05-22

Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Squamous Intraepithelial Lesions of the Cervix

NCT07594327 2026-05-22

Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer

Enrolling by invitation

21 enrolled

Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Sexuality

NCT07218003 2026-05-04

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Phase 1 Enrolling by invitation

149 enrolled

BreastGastrointestinalGenitourinaryGynecologicThoracic

Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

IMPROVE

PETCVOCC

Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening

Primary HPV Self-Collection in Indonesia

Late Side-effects After Cervical Cancer Treatment - Prevention and Treatment

Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients

JANUS

ECCO

The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia

Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening

Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix

A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination Intervention

CNCMT

Effect of Nurse Navigation Program on Cervical Cancer Screening Behaviour of the Women Aged 30-65

A Review of Cervical Cancer Screening Practices in Women Age >65

ACCESS